To make oral absorption possible, it relies on a specialized absorption enhancer called SNAC
Though to our knowledge there are no studies on interactions between GLP-1 and CB1 receptors in the habenula, VTA or other brain regions, there is evidence of reciprocal functional interactions between these two receptors peripherally [57]
Zepbounds active ingredient, tirzepatide, and Wegovys active ingredient, semaglutide, are contraindicated in patients with personal or family history of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Any claims about Omzo's non-GLP-1 programs should be verified directly at omzo.com before enrollment
Call us today at 509-392-5007 to schedule a consultation and learn how we can support your success with tailored solutions.